Physician profile
Rita E Marrero
NPI 1497868301
$992.31
in general payments reported to CMS, 2019-2025
10 companies · $17.63 in 2025
The $17.63 reported for 2025 was less than what a typical Advanced Practice Midwife provider received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $479 · 2022: $416 · 2023: $63.96 · 2024: $16.57 · 2025: $17.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $98.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $98.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $513.02 | 2021-2023 | |
| Daiichi Sankyo INC. | $235.33 | 2021-2024 | Injectafer |
| Evofem Biosciences, INC. | $65.60 | 2022 | |
| Hologic Sales and Service, LLC | $48.34 | 2022-2025 | Aptima, Thinprep 2000 Processor |
| Pfizer INC. | $36.35 | 2021-2022 | |
| Myovant Sciences INC. | $30.10 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.68 | 2022 | |
| Coopersurgical, INC. | $16.63 | 2022 | |
| Agile Therapeutics, INC. | $14.31 | 2023 | Twirla |
| Convatec INC. | $13.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rita Marrero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.